Work

Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis

Year: 2022

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-022-06621-4

Authors: Tal Sella, Pedro Exman, Siyang Ren, Taylor S. Freret, Katherine E. Economy, Wendy Y. Chen, Heather A. Parsons, Nancy U. Lin, Beverly Moy, Nadine M. Tung, Ann H. Partridge, Nabihah Tayob, Erica L. Mayer

Institutions: Dana-Farber Cancer Institute, Hospital Alemão Oswaldo Cruz, Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center

Language: English

Topic: Pregnancy and Medication Impact

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: American Physicians Fellowship for Medicine in Israel

OpenAlex ID: W4283066336

FWCI: 2.648

Cites: 29

Cited by: 13

Related to: 10